Format

Send to

Choose Destination
Ann Afr Med. 2009 Apr-Jun;8(2):76-80. doi: 10.4103/1596-3519.56232.

The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia.

Author information

1
Department of Obstetrics and Gynaecology, Aminu Kano Teaching Hospital/ Bayero University, Kano, Nigeria. jtukur@yahoo.com

Abstract

BACKGROUND:

Pre-eclampsia and eclampsia are important causes of maternal and perinatal morbidity and mortality in the developing countries. There is need to provide the most effective management to pre-eclamptic and eclamptic patients. There is now evidence that magnesium sulphate is the most effective anticonvulsant.

METHOD:

In this article , a literature review was made on the contribution of pre-eclampsia and eclampsia to maternal mortality and how it can be curtailed by the use of magnesium sulphate.

RESULTS:

The drug is administered by the Pritchard or Zuspan regimen, although modifications in the two protocols have been reported.

CONCLUSION:

A Nigerian national protocol has been developed on its use. There is need for further training of health workers on how to use this important drug.

PMID:
19805935
DOI:
10.4103/1596-3519.56232
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center